Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Cash flows from operating activities:
Net income	$ 274.8	$ 209.7
Depreciation and amortization	284.1	275.0
Change in fair value of contingent consideration	0.0	(31.8)
Accrual for acquisition termination fee	0.0	45.0
Net changes in operating capital	(302.5)	(188.8)
Other non-cash items	184.8	124.2
Net cash provided by operating activities	441.2	433.3
Cash flows from investing activities:
Purchases of property, plant and equipment	(281.2)	(247.5)
Acquisitions of businesses and assets, net of cash acquired, and other	(241.8)	(40.7)
Net cash used in investing activities	(523.0)	(288.2)
Cash flows from financing activities:
Proceeds from long-term debt, net of issuance costs	2,807.8	1,652.0
Repayments of long-term debt	(2,749.2)	(1,490.4)
Net repayments of short-term debt	(3.4)	(335.5)
Net proceeds related to share-based compensation awards	6.5	2.2
Dividends on common stock	0.0	(1.5)
Issuance of common stock for employee stock purchase plan	5.9	5.8
Net cash provided by (used in) financing activities	67.6	(167.4)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	3.1	1.2
Net decrease in cash, cash equivalents, and restricted cash	(11.1)	(21.1)
Cash, cash equivalents, and restricted cash at beginning of period	120.9	138.6
Cash, cash equivalents, and restricted cash at end of period	109.8	117.5
Reconciliation of cash flow information:
Cash and cash equivalents	109.7	117.3
Restricted cash included in other current assets	0.1	0.2
Total cash, cash equivalents, and restricted cash	$ 109.8	$ 117.5